ctDNA and bladder cancer: Current understanding and beyond

Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to improve treatment decision-making in the future.

Speakers

• Prof. Thomas Powles
  Barts Centre, London, UK. Read more
• Prof. James Catto
  University of Sheffield and Sheffield Teaching Hospitals NHS Trust, Sheffield, UK. Read more

Speaker disclosures

Prof. Thomas Powles

• Consultancy/honorarium: AstraZeneca, BMS, Exelixis, Incyte, Ipsen, Merck, MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono (EMD in US), Astellas, Johnson & Johnson, Eisai, Roche.
• Grant/funding to institution: AstraZeneca, Roche, BMS, Exelixis, Ipsen Merck MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono (EMD in US), Astellas , Johnson & Johnson, Eisai.
• Travel/accommodation: Roche, Pfizer, MSD, AstraZeneca, Ipsen.

Prof. James Catto

• Consulting fees: AstraZeneca, Ferring, Ipsen, Roche, and Janssen; 
• Speaker fees: Bristol Myers Squibb, Pfizer, Merck Sharp & Dohme, Janssen, Astellas, Nucleix, and Roche; 
• Honoraria for membership in advisory boards: Ferring, Roche, Gilead, Photocure, Pfizer, Bristol Myers Squibb, QED Therapeutics, and Janssen; 
• Research funding: Roche.

Financial disclosure

This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

Disclaimer

Any information provided and opinions expressed do not necessarily reflect the views of Springer Medizin GmbH. Springer Medizin GmbH and its employees, agents and subcontractors are not responsible or in any way liable for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising therefrom. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Please consult the latest prescribing information from the manufacturer before issuing prescriptions for any products mentioned.